Cite

Nanoceria suppresses multiple low doses of streptozotocin-induced Type 1 diabetes by inhibition of Nrf2/NF-κB pathway and reduction of apoptosis.

MLA

Khurana, Amit, et al. “Nanoceria Suppresses Multiple Low Doses of Streptozotocin-Induced Type 1 Diabetes by Inhibition of Nrf2/NF-ΚB Pathway and Reduction of Apoptosis.” Nanomedicine (London, England), vol. 13, no. 15, Aug. 2018, pp. 1905–22. EBSCOhost, https://doi.org/10.2217/nnm-2018-0085.



APA

Khurana, A., Tekula, S., & Godugu, C. (2018). Nanoceria suppresses multiple low doses of streptozotocin-induced Type 1 diabetes by inhibition of Nrf2/NF-κB pathway and reduction of apoptosis. Nanomedicine (London, England), 13(15), 1905–1922. https://doi.org/10.2217/nnm-2018-0085



Chicago

Khurana, Amit, Sravani Tekula, and Chandraiah Godugu. 2018. “Nanoceria Suppresses Multiple Low Doses of Streptozotocin-Induced Type 1 Diabetes by Inhibition of Nrf2/NF-ΚB Pathway and Reduction of Apoptosis.” Nanomedicine (London, England) 13 (15): 1905–22. doi:10.2217/nnm-2018-0085.